Bio Houston 2007 Annual Luncheon
Ivor Royston, M.D.
Founder of Hybritech and Founding Managing Partner of Forward Ventures
Dr. Royston is considered to be the father of biotechnology in San Diego, having founded Hybritech, Inc. in 1978 (later acquired by Eli Lilly) and Idec Pharmaceuticals in 1986 (which later merged with Biogen). Dr. Royston is also the founding managing partner of Forward Ventures, a leading life-science venture capital firm located in San Diego investing in pharmaceutical products and medical devices with over $500 million in capital under management.
Dr. Royston has been instrumental in the formation, financing, and development of numerous successful public biotechnology companies, including: Applied Molecular Evolution (acquired by Eli Lilly); Combichem (acquired by DuPont); Corixa (acquired by GlaxoSmithKline); Favrille; Genesys Therapeutics (merged with Somatix and acquired by Cell Genesys); and Triangle Pharmaceuticals (acquired by Gilead). Dr. Royston has also authored over 100 scientific publications and is a nationally-recognized physician-scientist in the area of cancer immunology.
Dr. Royston was previously the Founding President and CEO of the Sidney Kimmel Cancer Center (1990-2000) and on the faculty of the medical school and cancer center of the University of California, San Diego (1977-1990). He received his B.A. (1967) and M.D. (1970) degrees from the Johns Hopkins University and completed post-doctoral training in internal medicine and medical oncology at Stanford University. In 1997, President Clinton appointed Dr. Royston to a six-year term on the National Cancer Advisory Board.